EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Pilot E2 for Hypogonadal Women With CFBD

Phase 4

Withdrawn

Conditions: Cystic Fibrosis Related Bone Disease

Interventions: Other: Placebo
Drug: Estradiol 2 mg

First Posted Date: 2018-10-30

Last Posted Date: 2019-04-18

Lead Sponsor: Emory University

Registration Number: NCT03724955

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy

Phase 2

Active, not recruiting

Conditions: Stage IIIC Skin Melanoma
Cutaneous Melanoma, Stage IV
Stage III Melanoma
Stage IIIA Skin Melanoma
Unresectable Melanoma
Cutaneous Melanoma, Stage III
Stage IV Skin Melanoma
Stage IIIB Skin Melanoma

Interventions: Drug: Nivolumab
Biological: Rituximab and Hyaluronidase Human
Drug: Ipilimumab

First Posted Date: 2018-10-25

Last Posted Date: 2024-04-03

Lead Sponsor: Emory University

Target Recruit Count: 15

Registration Number: NCT03719131

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone

Phase 4

Terminated

Conditions: Tenosynovitis

Interventions: Drug: Control Group (corticosteroid alone)

First Posted Date: 2018-10-15

Last Posted Date: 2022-10-12

Lead Sponsor: Emory University

Target Recruit Count: 62

Registration Number: NCT03704584

Locations: 🇺🇸
Emory Clinic A, Clifton Road Clinic, Atlanta, Georgia, United States
🇺🇸
12 Executive Park Drive, Atlanta, Georgia, United States
🇺🇸
Emory Healthcare Orthopaedics and Spine Center, Atlanta, Georgia, United States

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Phase 4

Completed

Conditions: Influenza A Subtype H5N1 Infection

Interventions: Biological: Seasonal Influenza Vaccine

First Posted Date: 2018-10-09

Last Posted Date: 2020-03-11

Lead Sponsor: Emory University

Target Recruit Count: 12

Registration Number: NCT03701061

Locations: 🇺🇸
The Hope Clinic of Emory University, Decatur, Georgia, United States

Expiratory Muscle Strength Training and Phonation Resistance Training Exercises For Elderly Patients With Vocal Fold Atrophy

Not Applicable

Terminated

Conditions: Vocal Cord Atrophy
Voice Disorder
Presbyphonia

Interventions: Device: EMST
Behavioral: PhoRTE

First Posted Date: 2018-10-04

Last Posted Date: 2021-08-30

Lead Sponsor: Emory University

Target Recruit Count: 24

Registration Number: NCT03696576

Locations: 🇺🇸
University of Pittsburgh Voice Center, Pittsburgh, Pennsylvania, United States
🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Acceptability, Feasibility and Safety of a Yoga Program for Chronic Pain in Sickle Cell Disease

Not Applicable

Terminated

Conditions: Sickle Cell Disease

Interventions: Behavioral: Part A Survey
Behavioral: Part B Yoga Program

First Posted Date: 2018-10-03

Last Posted Date: 2021-07-16

Lead Sponsor: Emory University

Target Recruit Count: 35

Registration Number: NCT03694548

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer

Phase 1

Recruiting

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Biological: Ipilimumab
Biological: VX15/2503
Biological: Nivolumab

First Posted Date: 2018-10-01

Last Posted Date: 2023-10-05

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT03690986

Locations: 🇺🇸
Emory University Hospital Midtown, Atlanta, Georgia, United States

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

Phase 2

Completed

Conditions: HER2/Neu Negative
Progesterone Receptor Positive
Estrogen Receptor Positive
Metastatic Breast Carcinoma
Anatomic Stage IV Breast Cancer AJCC v8
Metastatic Malignant Neoplasm in the Bone
Prognostic Stage IV Breast Cancer AJCC v8

Interventions: Drug: Anastrozole
Drug: Exemestane
Drug: Fulvestrant
Drug: Letrozole
Drug: Palbociclib
Radiation: Radiation Therapy
Drug: Tamoxifen

First Posted Date: 2018-10-01

Last Posted Date: 2023-11-15

Lead Sponsor: Emory University

Target Recruit Count: 38

Registration Number: NCT03691493

Locations: 🇺🇸
Grady Health System, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States

and more 7 locations

The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics

Phase 4

Terminated

Conditions: Influenza

Interventions: Biological: FLUARIX QUADRIVALENT

First Posted Date: 2018-09-27

Last Posted Date: 2022-07-13

Lead Sponsor: Emory University

Target Recruit Count: 39

Registration Number: NCT03686514

Locations: 🇺🇸
The Hope Clinic of the Emory Vaccine Center, Atlanta, Georgia, United States

Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases

Not Applicable

Completed

Conditions: Invasive Malignant Neoplasm
Metastatic Malignant Neoplasm in the Brain

Interventions: Procedure: Dynamic Susceptibility Contrast-MRI (DSC-MRI)
Procedure: Magnetic Resonance Imaging (MRI)

First Posted Date: 2018-09-21

Last Posted Date: 2024-01-11

Lead Sponsor: Emory University

Target Recruit Count: 8

Registration Number: NCT03680144

Locations: 🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy